GLP-1 awareness among Colorado PCPs has grown significantly, and many are now comfortable prescribing semaglutide for appropriate patients
By month 3, many patients report dropping 1015 pounds, and continued progress continues into months 46 when the dose may be increased to enhance results
Very few post-surgical patients need doses above 8 mg
Patients can expect the following benefits: Decreased appetite Improved blood sugar control Increased fat loss Reduced risk of specific health conditions, such as hypertension and elevated cholesterol levels
As peptide science continues progressing, professional suppliers will likely remain essential within scientific innovation and advanced laboratory development
Athlete-focused programs represent 12%, driven by structured sports nutrition and endurance supplementation, strengthening diversified channel adoption across consumer groups